---
title: "McKesson declares Q3 2026 distribution of R$ 0.8 per unit, payable Oct. 7"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293663170.md"
description: "McKesson declared a Q3 2026 distribution of R$ 0.8 per unit for ISIN BRM1CKBDR004. Holders on record as of August 28 are entitled to this distribution, with payments scheduled for October 7."
datetime: "2026-07-23T20:26:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293663170.md)
  - [en](https://longbridge.com/en/news/293663170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293663170.md)
generator: "portal-rs"
---

# McKesson declares Q3 2026 distribution of R$ 0.8 per unit, payable Oct. 7

-   McKesson declared a 2026 third-quarter distribution of R$ 0.8 per unit (ISIN BRM1CKBDR004). \* Holders on Aug. 28 will be entitled to the distribution. \* Payment is scheduled for Oct. 7. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MCK.US](https://longbridge.com/en/quote/MCK.US.md)

## Related News & Research

- [McKesson SVP, Controller & CAO Napoleon B. Rutledge Jr disposes of 111 common shares worth $98,951.95](https://longbridge.com/en/news/298627514.md)
- [McKesson (NYSE:MCK) Earns "Sector Perform" Rating from Royal Bank Of Canada](https://longbridge.com/en/news/298930619.md)
- [McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal](https://longbridge.com/en/news/298922857.md)
- [Waverly Advisors LLC Has $4.69 Million Stake in McKesson Corporation $MCK](https://longbridge.com/en/news/298704960.md)
- [McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates](https://longbridge.com/en/news/298324139.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**